A study in the journal Pediatrics evaluated the efficacy of primary BNT162b2, mRNA-1273, and heterologous mRNA Covid-19 vaccines in preventing hospitalization amongst adolescents in Sweden, Norway, Finland, and Denmark. It found that vaccine effectiveness against hospitalization ranged from 73% to 86% at six months, with the protection remaining consistent up to a year, including during the Omicron wave.
Months After Being Notified, a Software Vendor is Still Exposing Confidential and Sealed Court Records
In a special edition of “No need to hack when it’s leaking,” DataBreaches reports on a software vendor that, despite multiple attempts by multiple parties,
